Dezamizumab (GSK 2398852) 是一种完全人源化的重组单克隆 IgG1 抗血清淀粉样蛋白 P 成分 (SAP) 抗体，具有潜在的抗淀粉样蛋白活性。Dezamizumab 触发淀粉样蛋白的免疫治疗清除。Dezamizumab 可用于淀粉样轻链 (AL) 淀粉样变性的研究。
| 生物活性 | Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonalIgG1anti-serum amyloid P component (SAP)antibody, with potential anti-amyloid activity. Dezamizumab triggers immunotherapeutic clearance of amyloid. Dezamizumab can be used in research of Amyloid light-chain (AL) amyloidosis[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
